These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 16026704)
1. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin. Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704 [TBL] [Abstract][Full Text] [Related]
2. 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice. Liu Z; Stevenson GD; Barrett HH; Kastis GA; Bettan M; Furenlid LR; Wilson DW; Woolfenden JM; Pak KY Nucl Med Commun; 2004 Jul; 25(7):711-20. PubMed ID: 15208499 [TBL] [Abstract][Full Text] [Related]
3. In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors. Muzzammil T; Moore MJ; Ballinger JR Cancer Biother Radiopharm; 2000 Aug; 15(4):339-46. PubMed ID: 11041018 [TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. Ballinger JR; Bannerman J; Boxen I; Firby P; Hartman NG; Moore MJ J Nucl Med; 1996 Sep; 37(9):1578-82. PubMed ID: 8790223 [TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumors. Ballinger JR; Muzzammil T; Moore MJ J Nucl Med; 1997 Dec; 38(12):1915-9. PubMed ID: 9430469 [TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin. Gomes CM; Abrunhosa AJ; Pauwels EK; Botelho MF Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044 [TBL] [Abstract][Full Text] [Related]
7. Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function. Muzzammil T; Moore MJ; Hedley D; Ballinger JR Br J Cancer; 2001 Feb; 84(3):367-73. PubMed ID: 11161402 [TBL] [Abstract][Full Text] [Related]
8. Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function. Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1529-31. PubMed ID: 14579093 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line. Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941 [TBL] [Abstract][Full Text] [Related]
10. 99Tcm-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancer. Muzzammil T; Ballinger JR; Moore MJ Nucl Med Commun; 1999 Feb; 20(2):115-22. PubMed ID: 10088159 [TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance. Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325 [TBL] [Abstract][Full Text] [Related]
12. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes? Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794 [TBL] [Abstract][Full Text] [Related]
13. Imaging recognition of multidrug resistance in human breast tumors using 99mTc-labeled monocationic agents and a high-resolution stationary SPECT system. Liu Z; Stevenson GD; Barrett HH; Kastis GA; Bettan M; Furenlid LR; Wilson DW; Woolfenden JM Nucl Med Biol; 2004 Jan; 31(1):53-65. PubMed ID: 14741570 [TBL] [Abstract][Full Text] [Related]
14. The value of Tc-99m tetrofosmin scintimammography in the assessment of P-glycoprotein in patients with breast cancer. Silov G; Erdoğan Z; Özdal A; Tutuş A; Tekin Y; Karaman H; Turhal Ö Hell J Nucl Med; 2013; 16(3):218-22. PubMed ID: 24137583 [TBL] [Abstract][Full Text] [Related]
15. Limitations of (99m)Tc tetrofosmin in assessing reversal effects of verapamil on the function of multi-drug resistance associated protein 1. Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N Nucl Med Commun; 2004 Jun; 25(6):585-9. PubMed ID: 15167518 [TBL] [Abstract][Full Text] [Related]
16. Different Efflux Transporter Affinity and Metabolism of Kobayashi M; Tsujiuchi T; Okui Y; Mizutani A; Nishi K; Nakanishi T; Nishii R; Fukuchi K; Tamai I; Kawai K Pharm Res; 2018 Nov; 36(1):18. PubMed ID: 30498970 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging. Tatsumi M; Tsuruo T; Nishimura T Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):288-94. PubMed ID: 12002701 [TBL] [Abstract][Full Text] [Related]
18. Effect of asiaticoside on 99mTc-tetrofosmin and 99mTc-sestamibi uptake in MCF-7 cells. Al-Saeedi FJ; Bitar M; Pariyani S J Nucl Med Technol; 2011 Dec; 39(4):279-83. PubMed ID: 22080437 [TBL] [Abstract][Full Text] [Related]
19. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients. Sergieva SB; Timcheva KV; Hadjiolov ND J BUON; 2006; 11(1):61-8. PubMed ID: 17318954 [TBL] [Abstract][Full Text] [Related]
20. Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines. Rodrigues M; Kalinowska W; Zielinski C; Sinzinger H Nucl Med Commun; 2001 Jun; 22(6):645-50. PubMed ID: 11403175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]